Forge Biologics, Case Western train gene therapy workers

By The Science Advisory Board staff writers

July 6, 2021 -- Contract development and manufacturing organization Forge Biologics and Case Western Reserve University in Cleveland announced that they will collaborate on a gene therapy workforce development program.

The program is called Forge Forward and is a partnership with the university's National Center for Regenerative Medicine (NCRM). Its goal is to attract researchers with good manufacturing practice (GMP) training to work with Forge on gene therapy.

Candidates selected for the program will learn how to work in both research and GMP environments. They will also get hands-on experience in cell culture and sterile techniques through lecture and laboratory teaching.

Forge secures $120M to increase AAV manufacturing capacity
Contract development and manufacturing organization Forge Biologics has closed $120 million in financing to accelerate the expansion of its adeno-associated...

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter